MediciNova
MNOV
40 hedge funds and large institutions have $12.1M invested in MediciNova in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 19 reducing their positions, and 2 closing their positions.
1,400% more call options, than puts
Call options by funds: $45K | Put options by funds: $3K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less capital invested
Capital invested by funds: $12.6M → $12.1M (-$505K)
1.27% less ownership
Funds ownership: 12.66% → 11.39% (-1.3%)
2% less funds holding
Funds holding: 41 → 40 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
74% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
+$80.2K |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$17.6K |
| 3 |
BlackRock
New York
|
+$7.1K |
| 4 |
Renaissance Technologies
New York
|
+$4.81K |
| 5 |
Millennium Management
New York
|
+$722 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$494K |
| 2 |
JP Morgan Chase
New York
|
-$167K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$115K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$98.3K |
| 5 |
E
Ergoteles
New York
|
-$95.6K |
MNOV Hedge Fund Activity: Q1 2023 in Review
40 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q1 2023, worth a combined $12.1M — down 4% from $12.6M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of MNOV and 1 opened new positions — a net loss of 1 holder — while 19 trimmed existing stakes and 5 added.
The largest buyer was Dimensional Fund Advisors, adding an estimated $80.2K. The largest seller was Jane Street, cutting an estimated $494K.
- 40 institutional investors held MediciNova (MNOV) as of Q1 2023, down from 41 in Q4 2022.
- Funds reported $12.1M of MediciNova stock for Q1 2023, down 4% quarter-over-quarter.
- 1 fund opened new MediciNova positions in Q1 2023 and 2 closed out, a net change of -1 holder.
- The largest MediciNova buyer in Q1 2023 was Dimensional Fund Advisors, an estimated $80.2K added.
- The largest MediciNova seller in Q1 2023 was Jane Street, an estimated $494K sold.
Based on aggregated 13F filings for Q1 2023.